General Cancer
EP. 1: TRK as Ideal Candidate for Targeted Therapy
Watch
EP. 2: Scientific Rationale for Development of TRK Inhibitors
EP. 3: Early Development of TRK Inhibitor-Larotrectinib
EP. 4: Efficacy of TRKi-Larotrectinib Among Tumor Types
EP. 5: Safety and Efficacy Profile for TRKi-Larotrectinib
EP. 6: Patient Selection for TRKi-Larotrectinib
EP. 7: TRKi: High Response Rate in Patients With Primary CNS Disease
EP. 8: Entrectinib-A Multitargeted TKI
EP. 9: Entrectinib-Selective ROS Inhibition
EP. 10: Investigational Approaches for TRK-Fusion Cancers
EP. 11: NGS Testing to Detect TRK Fusions
EP. 12: Molecular Testing for RAI-Refractory Thyroid Cancer
EP. 13: Dirty Kinases in TRK-Fusion Malignancies
